"Dr. Sabbagh explains that traditional endpoints like overall survival often require long follow-ups, delaying access to potentially life-saving treatments. His research leverages baseline clinical characteristics and PSA changes over four months to accelerate predictions of trial outcomes. "
It would be cool to know exactly which parameters they use, the AI would take care or their inegration and interplay...